- $2.28m
- $392.49m
- -$98.70m
Annual balance sheet for Beneficient, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 12.5 | 70.6 | 8.73 | 7.91 |
| Net Total Receivables | 2.86 | 2.01 | 11.3 | 2.84 |
| Prepaid Expenses | ||||
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 4.58 | 7.34 | 4.34 | 2.33 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Other Assets | ||||
| Total Assets | 2,816 | 3,141 | 2,911 | 369 |
| Payable / Accrued | ||||
| Notes Payable / Short Term Debt | ||||
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 2,195 | 1,705 | 1,518 | 603 |
| Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| Other Equity | ||||
| Total Equity | 622 | 1,436 | 1,392 | -234 |
| Total Liabilities & Shareholders' Equity | 2,816 | 3,141 | 2,911 | 369 |
| Total Common Shares Outstanding |